or Try an Advanced Search...

    Treatment Of Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    PYXS C Pyxis Oncology, Inc. 12.18
    LYEL F Lyell Immunopharma, Inc. 0.00
    VCNX F Vaccinex, Inc. -6.06
    PPBT F Purple Biotech Ltd. -0.35
    APLM F Apollomics Inc. -7.95
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Non Small Cell Lung Cancer Antineoplastic Drugs Biotechnology Clinical Medicine Medicine Acute Myeloid Leukemia Biology Cancer Treatment Immune System Immunology Small Cell Lung Cancer Solid Tumors Advanced Solid Tumors Antibodies Antibody Antibody Drug Conjugate Autoimmune Disorders Biopharmaceutical Blood Cancers

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR C Loncar Cancer Immunotherapy ETF 1.23
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.3
    GNOM F Global X Genomics & Biotechnology ETF 0.26
    IWC A iShares Microcap ETF 0.08
    IBBQ B Invesco Nasdaq Biotechnology ETF 0.03
    View all Treatment Of Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare BBC to IWC Compare CNCR to IBBQ Compare CNCR to IWC

        Treatment Of Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 7 LYEL Lyell Immunopharma: Q3 Earnings Snapshot
        Nov 7 LYEL Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
        Nov 5 LYEL Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
        Nov 5 VCNX Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
        Nov 5 PPBT Purple Biotech Unveils Promising Biomarker for Cancer Therapy
        Nov 4 PPBT Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Non Small Cell Lung Cancer Antineoplastic Drugs Biotechnology Clinical Medicine Medicine Acute Myeloid Leukemia Biology Cancer Treatment Immune System Immunology Small Cell Lung Cancer Solid Tumors Advanced Solid Tumors Antibodies Antibody Antibody Drug Conjugate Autoimmune Disorders Biopharmaceutical Blood Cancers
        Treatment Of Non Small Cell Lung Cancer

        Treatment for non-small cell lung cancer (NSCLC) depends on the stage of the cancer and the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

        Browse All Tags